Covance To Present at the UBS Global Life Sciences Conference
22 September 2008 - 11:00PM
PR Newswire (US)
PRINCETON, N.J., Sept. 22 /PRNewswire-FirstCall/ -- Covance Inc.
(NYSE: CVD) today announced that it will present at the UBS Global
Life Sciences Conference on Tuesday, September 23, 2008 at 10:00 am
(ET). Investors may access a live webcast of the presentation at
http://www.covance.com/. In order to register and download any
necessary software, please log on 10 minutes early. Covance, with
headquarters in Princeton, New Jersey, is one of the world's
largest and most comprehensive drug development services companies
with annual revenues greater than $1.5 billion, global operations
in more than 20 countries, and more than 9,000 employees worldwide.
Information on Covance's products and services, recent press
releases, and SEC filings can be obtained through its website at
http://www.covance.com/. DATASOURCE: Covance Inc. CONTACT: Covance
Inc. Investor Relations, +1-609-452-4807 Web site:
http://www.covance.com/
Copyright